Skip to content

SMOT · BATS · ETF

VanEck Morningstar SMID Moat ETF (SMOT) Price, Holdings & Fees

$385.12−1.04%−$4.03End-of-day price as of Oct 9, 2026

VanEck Morningstar SMID Moat ETF (SMOT) closed at $385.12 on Oct 9, 2026, down 1.04% from the previous close of $389.15.

Share price, past year

1Y +0.79%

52-week range $352.77 – $396.80. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$385.12
Sep 30, 2026$383.88
Aug 31, 2026$375.14
Jul 31, 2026$357.06
Jun 30, 2026$374.50
May 29, 2026$379.80
Apr 30, 2026$365.33
Mar 31, 2026$370.12
Feb 27, 2026$391.63
Jan 30, 2026$373.51
Dec 31, 2025$390.13
Nov 28, 2025$370.90
Oct 31, 2025$389.61

Key statistics

Expense ratio
0.49%
as of Jan 31, 2026
Net assets
$334.4M
as of Jun 30, 2026
Holdings
110
as of Jun 30, 2026
52-week range
$352.77 – $396.80

VanEck Morningstar SMID Moat ETF's expense ratio is 0.49%: $49.00 a year on $10,000 invested.

Holdings

VanEck Morningstar SMID Moat ETF held 110 investments worth $334.35M as of Jun 30, 2026. Its largest holding was Acuity Inc, at 1.70% of the fund.

VanEck Morningstar SMID Moat ETF largest holdings by share of net assets
#Holding% of fundValue
1Acuity Inc1.70%$5.68M
2Bio-Techne Corp1.66%$5.56M
3Masco Corp1.56%$5.22M
4Biogen Inc1.45%$4.86M
5Royalty Pharma PLC1.45%$4.85M
6Block Inc1.42%$4.75M
7Corteva Inc1.42%$4.75M
8Amcor PLC1.39%$4.64M
9Gentex Corp1.39%$4.63M
10Norwegian Cruise Line Holdings Ltd1.38%$4.62M
11Carnival Corp Ltd1.37%$4.59M
12IQVIA Holdings Inc1.37%$4.57M
13Ionis Pharmaceuticals Inc1.36%$4.56M
14Airbnb Inc1.35%$4.52M
15Brown-Forman Corp1.33%$4.43M
16CNH Industrial NV1.31%$4.40M
17Datadog Inc1.29%$4.31M
18TransUnion1.29%$4.31M
19Cigna Group/The1.27%$4.23M
20DuPont de Nemours Inc1.26%$4.20M
21BioMarin Pharmaceutical Inc1.24%$4.16M
22Mondelez International Inc1.24%$4.16M
23Stifel Financial Corp1.24%$4.15M
24Lamb Weston Holdings Inc1.24%$4.15M
25Kraft Heinz Co/The1.24%$4.14M

Top 25 of 110 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

VanEck Morningstar SMID Moat ETF holdings by asset type
Asset type% of fund
Stocks99.46%
VanEck Morningstar SMID Moat ETF holdings by country, largest 7
Country% of fund
United States89.86%
Bermuda2.75%
Netherlands2.69%
United Kingdom1.45%
Jersey1.39%
Ireland0.71%
Curaçao0.60%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, VanEck Morningstar SMID Moat ETF's total return was +10.48%, as reported to the SEC.

VanEck Morningstar SMID Moat ETF monthly total returns
MonthTotal return
Jun 30, 2026+1.87%
May 31, 2026+2.18%
Apr 30, 2026+6.14%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
VanEck Morningstar SMID Moat ETF
Ticker
SMOT
Exchange
BATS
Fund type
ETF
Trust
VanEck ETF Trust
SEC series ID
S000077508
SEC CIK
0001137360
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by VanEck ETF Trust, the trust behind VanEck Morningstar SMID Moat ETF, and cover all of its funds.

Frequently asked questions

What is SMOT's price?

VanEck Morningstar SMID Moat ETF (SMOT) closed at $385.12 on Oct 9, 2026, down 1.04% from the previous close of $389.15.

What is SMOT's expense ratio?

VanEck Morningstar SMID Moat ETF's expense ratio is 0.49%: $49.00 a year on $10,000 invested.

What does SMOT hold?

VanEck Morningstar SMID Moat ETF held 110 investments worth $334.35M as of Jun 30, 2026. Its largest holding was Acuity Inc, at 1.70% of the fund. Its five largest holdings were Acuity Inc, Bio-Techne Corp, Masco Corp, Biogen Inc, Royalty Pharma PLC.

How has SMOT performed?

Over the 3 months to Jun 30, 2026, VanEck Morningstar SMID Moat ETF's total return was +10.48%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 26, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Jan 31, 2026. Prices are generated sample data for development. Data sources and disclosures